SAN FRANCISCO, Jan.
NEW YORK, Jan. 9 - Bruker AXS on Wednesday said that the underwriters of its initial
This article is available to subscribers of BioInform.
NEW YORK, Jan. 8 — MorphoSys said Tuesday that it would expand its drug target identification and validation partnership with Cambridge, Mass.-based Biogen.
NEW YORK, Jan.
NEW YORK, Jan. 8 — Bayer Diagnostic and Burrill & Company said Tuesday that they had formed a new $50 million venture capital fund for diagnostic research.
NEW YORK, Jan. 8—Iceland's DeCode genetics will acquire MediChem Life Sciences in a stock-swap deal valued at roughly $84 million, the companies announced early on Tuesday.
This article has been updated from a previous version to clarify that Illumina is developing technologies for drug d
NEW YORK, Jan. 8—German functional genomics firm Atugen has struck a deal with Danish healthcare giant Novo Nordisk to jointly validate new targets for diabetes and related diseases, Atugen said on Tuesday.
Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.
Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.
Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.
In Nature this week: sequenced genomes of five additional Neanderthals, and more.